At the time of writing, Oncology Institute Inc [TOI] stock is trading at $2.61, down -1.51%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TOI shares have gain 4.40% over the last week, with a monthly amount glided 93.33%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Guggenheim started tracking the stock with Buy rating on September 14, 2022, and set its price target to $7. On August 15, 2022, Jefferies initiated with a Buy rating and assigned a price target of $10 on the stock.
For the past year, the stock price of Oncology Institute Inc fluctuated between $0.13 and $3.50. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Oncology Institute Inc [NASDAQ: TOI] shares were valued at $2.61 at the most recent close of the market. An investor can expect a potential return of 206.51% based on the average TOI price forecast.
Analyzing the TOI fundamentals
According to Oncology Institute Inc [NASDAQ:TOI], the company’s sales were 393.41M for trailing twelve months, which represents an 16.88% jump. Gross Profit Margin for this corporation currently stands at 0.13% with Operating Profit Margin at -0.15%, Pretax Profit Margin comes in at -0.16%, and Net Profit Margin reading is -0.16%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -2.73 and Total Capital is -0.5. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of34.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.34 points at the first support level, and at 2.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.76, and for the 2nd resistance point, it is at 2.91.
Ratios To Look Out For
It is important to note that Oncology Institute Inc [NASDAQ:TOI] has a current ratio of 2.15. In addition, the Quick Ratio stands at 1.96 and the Cash Ratio stands at 0.95. Considering the valuation of this stock, the price to sales ratio is 0.50, the price to book ratio is 55.07.
Transactions by insiders
Recent insider trading involved Virnich Daniel, Chief Executive Officer, that happened on Mar 26 ’25 when 22640.0 shares were purchased. Chief Medical Officer, Podnos Yale completed a deal on Mar 26 ’25 to buy 9056.0 shares. Meanwhile, Director Pacala Mark L bought 90562.0 shares on Mar 26 ’25.
